Sernova (TSE:SVA) has released an update.
Sernova Corp., a clinical-stage biotech firm, has successfully closed an over-subscribed private placement, raising over $5.2 million. The company, known for its Cell Pouch System for treating chronic diseases like diabetes, is set to present recent clinical study data at the EASD Annual Meeting in Spain.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
